Addition of host genetic variants in a prediction rule for post meningitis hearing loss in childhood: a model updating study

BackgroundSensorineural hearing loss is the most common sequela in survivors of bacterial meningitis (BM). In the past we developed a validated prediction model to identify children at risk for post-meningitis hearing loss. It is known that host genetic variations, besides clinical factors, contribute to severity and outcome of BM. In this study it was determined whether host genetic risk factors improve the predictive abilities of an existing model regarding hearing loss after childhood BM.MethodsFour hundred and seventy-one Dutch Caucasian childhood BM were genotyped for 11 single nucleotide polymorphisms (SNPs) in seven different genes involved in pathogen recognition. Genetic data were added to the original clinical prediction model and performance of new models was compared to the original model by likelihood ratio tests and the area under the curve (AUC) of the receiver operating characteristic curves.ResultsAddition of TLR9-1237 SNPs and the combination of TLR2 + 2477 and TLR4 + 896 SNPs improved the clinical prediction model, but not significantly (increase of AUC’s from 0.856 to 0.861 and from 0.856 to 0.875 (p = 0.570 and 0.335, respectively). Other SNPs analysed were not linked to hearing loss.ConclusionsAlthough addition of genetic risk factors did not significantly improve the clinical prediction model for post-meningitis hearing loss, AUC’s of the pre-existing model remain high after addition of genetic factors. Future studies should evaluate whether more combinations of SNPs in larger cohorts has an additional value to the existing prediction model for post meningitis hearing loss.

[1]  D. Grobbee,et al.  Hearing loss at school age in survivors of bacterial meningitis: assessment, incidence, and prediction. , 2003, Pediatrics.

[2]  H. Wagner,et al.  MyD88-dependent immune response contributes to hearing loss in experimental pneumococcal meningitis. , 2007, The Journal of infectious diseases.

[3]  A. Brand,et al.  Public health and valorization of genome-based technologies: a new model , 2011, Journal of Translational Medicine.

[4]  C. Terwee,et al.  Independent Validation of an Existing Model Enables Prediction of Hearing Loss after Childhood Bacterial Meningitis , 2013, PloS one.

[5]  S. Morré,et al.  Polymorphisms in Toll-Like Receptors 2, 4, and 9 Are Highly Associated with Hearing Loss in Survivors of Bacterial Meningitis , 2012, PloS one.

[6]  Toshihiro Tanaka,et al.  Prediction model for knee osteoarthritis based on genetic and clinical information , 2010, Arthritis Research & Therapy.

[7]  M. Lutz,et al.  TLR9 cooperates with TLR4 to increase IL-12 release by murine dendritic cells. , 2008, Molecular immunology.

[8]  S. Morré,et al.  Genetic variation of innate immune response genes in invasive pneumococcal and meningococcal disease applied to the pathogenesis of meningitis , 2011, Genes and Immunity.

[9]  S. Manolidis,et al.  P032: Clinical Predictors for Hearing Loss in Children with Bacterial Meningitis , 2003, Archives of otolaryngology--head & neck surgery.

[10]  A. Brand,et al.  The impact of genetics and genomics on public health , 2008, European Journal of Human Genetics.

[11]  I. Rudan,et al.  Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. , 2010, The Lancet. Infectious diseases.

[12]  G. Bonsel,et al.  Reliability and validity of comprehensive health status measures in children: The Child Health Questionnaire in relation to the Health Utilities Index. , 2002, Journal of clinical epidemiology.

[13]  E. Silverman,et al.  Single nucleotide polymorphisms in innate immunity genes: abundant variation and potential role in complex human disease , 2002, Immunological reviews.

[14]  H. Pfister,et al.  Nitrogen and Oxygen Molecules in Meningitis-Associated Labyrinthitis and Hearing Impairment , 2008, Infection.

[15]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[16]  D. Goldstein Common genetic variation and human traits. , 2009, The New England journal of medicine.

[17]  K. Marks,et al.  Clinical relevance of TLR2, TLR4, CD14 and FcγRIIA gene polymorphisms in Streptococcus pneumoniae infection , 2008, Immunology and cell biology.

[18]  P. Cayé-Thomasen,et al.  Factors associated with the occurrence of hearing loss after pneumococcal meningitis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  E. Mylanus,et al.  Dutch Cochlear Implant Group (CI-ON) Consensus Protocol on Postmeningitis Hearing Evaluation and Treatment , 2010, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[20]  A. Ryan,et al.  Fundamental Immune Mechanisms of the Brain and Inner Ear , 1995, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[21]  Y. Vergouwe,et al.  Validation, updating and impact of clinical prediction rules: a review. , 2008, Journal of clinical epidemiology.

[22]  Samir S. Shah,et al.  Early prediction of postmeningitic hearing loss in children using magnetic resonance imaging. , 2011, Archives of otolaryngology--head & neck surgery.

[23]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[24]  T. Huizinga,et al.  Genetic variants in the prediction of rheumatoid arthritis , 2010, Annals of the rheumatic diseases.

[25]  S. Morré,et al.  Single nucleotide polymorphisms in TLR9 are highly associated with susceptibility to bacterial meningitis in children. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  J. Ioannidis,et al.  Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement. , 2011, Journal of clinical epidemiology.

[27]  Sara M. Willems,et al.  A Methodological Perspective on Genetic Risk Prediction Studies in Type 2 Diabetes: Recommendations for Future Research , 2011, Current diabetes reports.

[28]  U. Koedel Toll-like receptors in bacterial meningitis. , 2009, Current topics in microbiology and immunology.

[29]  Ewout W Steyerberg,et al.  Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers , 2011, Statistics in medicine.

[30]  T. Fazili,et al.  Factors associated with the occurrence of hearing loss after pneumococcal meningitis. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  N. Obuchowski,et al.  Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.

[32]  N. Roizen,et al.  Etiology of hearing loss in children. Nongenetic causes. , 1999, Pediatric clinics of North America.

[33]  P. Brookhouser Fluctuating sensorineural hearing loss in children. , 2002, Otolaryngologic clinics of North America.

[34]  H. Wagner,et al.  Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4. , 2008, The Journal of infectious diseases.

[35]  J. Faber,et al.  A toll‐like receptor 4 variant is associated with fatal outcome in children with invasive meningococcal disease , 2009, Acta paediatrica.

[36]  G. Bonsel,et al.  Reliability and validity of the child health questionnaire-child form (CHQ-CF87) in a Dutch adolescent population , 2002, Quality of Life Research.

[37]  J. Concato,et al.  A simulation study of the number of events per variable in logistic regression analysis. , 1996, Journal of clinical epidemiology.

[38]  S. Morré,et al.  Toll-like receptor 9 polymorphisms are associated with severity variables in a cohort of meningococcal meningitis survivors , 2012, BMC Infectious Diseases.

[39]  J. Hazelzet,et al.  Host genetic determinants of Neisseria meningitidis infections. , 2003, The Lancet. Infectious diseases.

[40]  H. Wagner,et al.  MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNS. , 2004, Brain : a journal of neurology.

[41]  A. Brand Public health genomics--public health goes personalized? , 2011, European journal of public health.